REQUEST A DEMO
Total
USD $0.00
Search more companies

"Centrum Innowacji Farmaceutycznych" Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Miscellaneous Food Manufacturing | Toilet Preparation Manufacturing | Chemical and Allied Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Warehousing and Storage | Other Activities Related to Credit Intermediation
Full name: "Centrum Innowacji Farmaceutycznych" Sp. z o.o. Profile Updated: October 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

"Centrum Innowacji Farmaceutycznych" Sp. z o.o. is an enterprise in Poland, with the main office in Sieradz. The company operates in the Pharmaceutical Preparation Manufacturing sector. It was established on May 28, 2014. It currently has a total number of 5 (2014) employees. Its total assets decreased by 21.96% over the same period.

Headquarters
Ul. Wladyslawa Lokietka 10
Sieradz; Lodzkie; Postal Code: 98-200

Contact Details: Purchase the "Centrum Innowacji Farmaceutycznych" Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the "Centrum Innowacji Farmaceutycznych" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the "Centrum Innowacji Farmaceutycznych" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Centrum Innowacji Farmaceutycznych" Sp. z o.o. report to view the information.
Incorporation Date:
May 28, 2014
Key Executives
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after "Centrum Innowacji Farmaceutycznych" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-18.96%
Operating profit (EBIT)
-34.46%
Net Profit (Loss) for the Period
-34.46%
Total assets
-21.96%
Total equity
-25.03%
Return on Equity (ROE)
-14.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?